Yıl: 2019 Cilt: 35 Sayı: 1 Sayfa Aralığı: 9 - 14 Metin Dili: İngilizce DOI: 10.5146/tjpath.2018.01434 İndeks Tarihi: 06-05-2019

Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas

Öz:
Objective: The granulation pattern of pituitary tumors may be important to predict tumor behavior, treatment outcomes, and recurrences.Therefore, we compared densely granulated corticotroph tumor (DGCT) and sparsely granulated corticotroph tumor (SGCT) in terms ofclinicopathologic findings.Material and Method: A total of 41 patients (31 females/10 males) were assessed in the study. The granulation patterns were detected by PeriodicAcid-Schiff (PAS) and adrenocorticotropic hormone (ACTH) immunoreactivity. Diffuse and strong staining by PAS and ACTH were identifiedas DGCT, whereas faint staining by PAS and focal, weak staining by ACTH were identified as SGCT. Perinuclear ring-like patterns with lowmolecular weight keratin were identified as Crooke’s cell tumors. DGCTs and SGCTs were compared in terms of clinical findings and treatmentoutcomes.Results: The majority of the patients (71%) had DGCTs (n=29); whereas 24% of the patients had SGCTs (n=10) and 5% of the patients hadCrooke’s cell tumors (n=2). DGCTs and SGCTs were similar in terms of age, sex, estimated duration of disease, baseline cortisol and ACTH levels.SGCTs were larger than DGCTs (p=0.034). The remissions with surgery rates were similar between the groups; however, hypothalamic-pituitary-adrenal axis recovery time was longer in SGCTs (p=0.033). Persistent disease after surgery was slightly higher in DGCTs and recurrences werefrequent in SGCTs; however, the differences were not statistically significant.Conclusion: DGCTs are often small microadenomas, while SGCTs are larger. Recurrences were slightly more common in SGCTs; however,further studies including larger series are needed to be able to obtain more significant results.
Anahtar Kelime:

Konular: Patoloji Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM. The diagnosis of Cushing’s syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab.2008;93:1526-40.
  • Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline.JClinEndocrinolMetab.2015;100:2807-31.
  • Syro LV, Rotondo F, Cusimano MD, Di Ieva A, Horvath E, Restrepo LM, Wong M, Killinger DW, Smyth H, Kovacs K. Current status on histological classification in Cushing’sdisease. Pituitary.2015;18:217-24.
  • WorldHealthOrganizationClassificationofTumours.Pathology and Genetics of Tumours of Endocrine Organs. DeLellis RA, LloydRV,HeitzPU,EngC(eds).Lyon:IARCPress,2004.
  • World Health Organization Classification of Tumours of Endocrine Organs. Lloyd RV, Osamura RY, Klöppel G, Rosai J (eds). 4thed. Lyon: IARC Press,2017.
  • AsaSL,EzzatS.Thepathogenesisofpituitarytumors.AnnuRev Pathol2009;4:97-126.
  • Saeger W, Honegger J, Theodoropoulou M, Knappe UJ, Schöfl C, Petersenn S, Buslei R. Clinical Impact of the Current WHO Classification of Pituitary Adenomas. Endocr Pathol. 2016;27:104-14.
  • Mete O, Asa SL. Clinicopathological correlations in pituitary adenomas. Brain Pathology.2012;22:443-53.
  • Asa SL. Tumors of the Pituitary Gland. Fascicle 15, 4th Series. The Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology,2011.
  • Di Ieva A, Davidson JM, Syro LV, Rotondo F, Montoya JF, HorvathE,CusimanoMD,KovacsK.Crooke’scelltumorsofthe pituitary. Neurosurgery.2015;76:616-22.
  • Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK. The postoperativebasalcortisolandCRHtestsforpredictionoflong- term remission from Cushing’s disease after transsphenoidal surgery.JClinEndocrinolMetab.2011;96:2057-64.
  • WitekP,ZielińskiG,SzamotulskaK,MaksymowiczM,Kamiński G. Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. Eur J Endocrinol. 2016;174:539-49.
  • Mete O, Cintosun A, Pressman I, Asa SL. Epidemiology and biomarker profile of pituitary adenohypophysial tumors. Mod Pathol.2018;31:900-9.
  • Dekkers OM, Horváth-Puhó E, Jørgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP, Pereira AM, Sørensen HT. Multisystem morbidity and mortality in Cushing’s syndrome: A cohortstudy.JClinEndocrinolMetab.2013;98:2277-84.
  • ClaytonRN.MortalityinCushing’sdisease.Neuroendocrinology. 2010;92 Suppl1:71-6.
  • Pivonello R, De Leo M, Cozzolino A, Colao A. The treatmentof Cushing’s disease. Endocr Rev.2015;36:385-6.
  • Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: A retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 1995;80:3114-20.
  • Blevins LS Jr, Christy JH, Khajavi M, Tindall GT. Outcomes of therapy for Cushing’s disease due toadrenocorticotropin- secreting pituitary macroadenomas. J Clin Endocrinol Metab. 1998;83:63-7.
  • HagueK,PostKD,MorgelloS.AbsenceofperitumoralCrooke’s change is associated with recurrence in surgically treated Cushing’s disease. Surg Neurol.2000;53:77-81.
  • Fougner SL, Casar-Borota O, Heck A, Berg JP, Bollerslev J. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patientswithacromegaly.ClinEndocrinol(Oxf)2012;76:96-102.
  • Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, ViennetG,BonnevilleJF,AssakerR,AugerC,BrueT,Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G; Members of HYPOPRONOS, Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, LoiseauH,PassagiaJG,PateyM,PenfornisA,PoirierJY,Perrin G,TabarinA.Anewprognosticclinicopathologicalclassification of pituitary adenomas: a multicentric case–control study of 410 patientswith8yearspost-operativefollow-up.ActaNeuropathol. 2013;126:123-35.
  • KovacsK,RotondoF,HorvathE,SyroLV,DiIevaA,Cusimano MD,MunozDG.Lettertotheeditor.EndocrPathol.2015;26:93- 4.
APA ÇİFTÇİ DOĞANŞEN S, BİLGİÇ M, YENİDUNYA YALIN G, TANRIKULU S, yarman s (2019). Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. , 9 - 14. 10.5146/tjpath.2018.01434
Chicago ÇİFTÇİ DOĞANŞEN Sema,BİLGİÇ MEBRURE BİLGE,YENİDUNYA YALIN GÜLŞAH,TANRIKULU Seher,yarman sema Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. (2019): 9 - 14. 10.5146/tjpath.2018.01434
MLA ÇİFTÇİ DOĞANŞEN Sema,BİLGİÇ MEBRURE BİLGE,YENİDUNYA YALIN GÜLŞAH,TANRIKULU Seher,yarman sema Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. , 2019, ss.9 - 14. 10.5146/tjpath.2018.01434
AMA ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. . 2019; 9 - 14. 10.5146/tjpath.2018.01434
Vancouver ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. . 2019; 9 - 14. 10.5146/tjpath.2018.01434
IEEE ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s "Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas." , ss.9 - 14, 2019. 10.5146/tjpath.2018.01434
ISNAD ÇİFTÇİ DOĞANŞEN, Sema vd. "Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas". (2019), 9-14. https://doi.org/10.5146/tjpath.2018.01434
APA ÇİFTÇİ DOĞANŞEN S, BİLGİÇ M, YENİDUNYA YALIN G, TANRIKULU S, yarman s (2019). Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi, 35(1), 9 - 14. 10.5146/tjpath.2018.01434
Chicago ÇİFTÇİ DOĞANŞEN Sema,BİLGİÇ MEBRURE BİLGE,YENİDUNYA YALIN GÜLŞAH,TANRIKULU Seher,yarman sema Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi 35, no.1 (2019): 9 - 14. 10.5146/tjpath.2018.01434
MLA ÇİFTÇİ DOĞANŞEN Sema,BİLGİÇ MEBRURE BİLGE,YENİDUNYA YALIN GÜLŞAH,TANRIKULU Seher,yarman sema Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi, vol.35, no.1, 2019, ss.9 - 14. 10.5146/tjpath.2018.01434
AMA ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi. 2019; 35(1): 9 - 14. 10.5146/tjpath.2018.01434
Vancouver ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas. Türk Patoloji Dergisi. 2019; 35(1): 9 - 14. 10.5146/tjpath.2018.01434
IEEE ÇİFTÇİ DOĞANŞEN S,BİLGİÇ M,YENİDUNYA YALIN G,TANRIKULU S,yarman s "Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas." Türk Patoloji Dergisi, 35, ss.9 - 14, 2019. 10.5146/tjpath.2018.01434
ISNAD ÇİFTÇİ DOĞANŞEN, Sema vd. "Clinical Significance of Granulation Pattern in Corticotroph Pituitary Adenomas". Türk Patoloji Dergisi 35/1 (2019), 9-14. https://doi.org/10.5146/tjpath.2018.01434